(Q28208633)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

review article

1 reference

title

Tumour immunology, vaccination and escape strategies (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

author name string

Algarra I

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Collado A

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Garrido F

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 June 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Immunogenetics

4 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

177-183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1365-2370.2003.00384.X

In search of the 'missing self': MHC molecules and NK cell recognition

20 April 2017

2 references

https://api.crossref.org/works/10.1046/J.1365-2370.2003.00384.X

20 April 2017

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Identification of human cancers deficient in antigen processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2370.2003.00384.X

The HLA crossroad in tumor immunology

20 April 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Multiple mechanisms underlie HLA dysregulation in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Structural and functional analysis of beta2 microglobulin abnormalities in human lung and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Immunoselection by T lymphocytes generates repeated MHC class I-deficient metastatic tumor variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Natural history of HLA expression during tumour development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Implications for immunosurveillance of altered HLA class I phenotypes in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Multiple genetic alterations cause frequent and heterogeneous human histocompatibility leukocyte antigen class I loss in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Receptors for HLA class-I molecules in human natural killer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

New paths in human cancer serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

A new beta 2 microglobulin mutation found in a melanoma tumor cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

In vivo and in vitro generation of a new altered HLA phenotype in melanoma-tumour-cell variants expressing a single HLA-class-I allele

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

A listing of human tumor antigens recognized by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

High frequency of altered HLA class I phenotypes in invasive breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

High frequency of altered HLA class I phenotypes in laryngeal carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Multiple mechanisms generate HLA class I altered phenotypes in laryngeal carcinomas: high frequency of HLA haplotype loss associated with loss of heterozygosity in chromosome region 6p21

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

Expression analysis of classic and non-classic HLA molecules before interferon alfa-2b treatment of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2370.2003.00384.X

10.1046/J.1365-2370.2003.00384.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12786993%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference